Use of Cetuximab (CTX) in 1st-Line Therapy of Metastatic Colorectal Cancer (mCRC): Patient Characteristics, Safety and Effectiveness in the EREBUS Cohort

被引：0
|
作者：
Fourrier-Reglat, Annie [1 ]
Smith, Denis [2 ]
Rouyer, Magali [1 ]
Francois, Eric [3 ]
Mitry, Emmanuel [4 ]
Monnereau, Alain [5 ]
Sa-Cunha, Antonio [6 ]
Bignon, Emmanuelle [1 ]
Le Monies, Alise [1 ]
Lassalle, Regis [1 ]
Noize, Pernelle [1 ]
Moore, Nicholas [1 ]
机构：
[1] Bordeaux Univ, Bordeaux, France
[2] Teaching Hosp Bordeaux, Bordeaux, France
[3] Ctr Antoine Lacassagne, F-06054 Nice, France
[4] Inst Curie, St Cloud, France
[5] Inst Bergonie, Bordeaux, France
[6] Teaching Hosp P Brousse, Villejuif, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2012年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
990
引用
收藏
页码：458 / 459
页数：2
相关论文
共 50 条
  • [1] USE OF CETUXIMAB (CTX) IN 1ST-LINE THERAPY OF METASTATIC COLORECTAL CANCER (MCRC): PATIENT CHARACTERISTICS, SAFETY AND EFFECTIVENESS IN THE EREBUS COHORT
    Smith, D.
    Rouyer, M.
    Mitry, E.
    Francois, E.
    Monnereau, A.
    Sa-Cunha, A.
    Jove, J.
    Noize, P.
    Moore, N.
    Fourrier-Reglat, A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 219 - 219
  • [2] Use of cetuximab (CTX) in first -line therapy of metastatic colorectal cancer (mCRC): Patient characteristics, safety, and effectiveness in the EREBUS cohort
    Smith, Denis
    Rouyer, Magali
    Mitry, Emmanuel
    Francois, Eric
    Monnereau, Alain
    Cunha, Antonio Sa
    Bignon, Emmanuelle
    Le Monies, Alise
    Jove, Jeremy
    Noize, Pernelle
    Moore, Nicholas
    Fourrier-Reglat, Annie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Cetuximab with Irinotecan or Oxaliplatin for 1st-Line Metastatic Colorectal Cancer: Effectiveness in the EREBUS Cohort Compared to Pivotal Trials
    Noize, Pernelle
    Fourrier-Reglat, Annie
    Rouyer, Magali
    Grelaud, Angela
    Bignon, Emmanuelle
    de Sagazan, Alise Le Monies
    Lassalle, Regis
    Jove, Jeremy
    Monnereau, Alain
    Cunha, Antonio Sa
    Francois, Eric
    Mitry, Emmanuel
    Moore, Nicholas
    Smith, Denis
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 60 - 61
  • [4] Outcomes of cetuximab in 1st-line therapy for metastatic colorectal cancer (mCRC) according to tumor RAS/BRAF mutation (mt) status in the EREBUS cohort.
    Smith, Denis Michel
    Rouyer, Magali
    Francois, Eric
    Cunha, Antonio Sa
    Monnereau, Alain
    Yon, Edwige
    Bignon, Emmanuelle
    Droz-Perroteau, Cecile
    Noize, Pernelle
    Moore, Nicholas
    Fourrier-Reglat, Annie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] CETUXIMAB WITH IRINOTECAN OR OXALIPLATIN FOR 1ST-LINE METASTATIC COLORECTAL CANCER: UPDATED DATA OF EFFECTIVENESS IN THE EREBUS COHORT COMPARED TO PIVOTAL TRIALS
    Denis, Smith
    Magali, Rouyer
    Eric, Francois
    Emmanuel, Mitry
    Alain, Monnereau
    Antonio, Sa-cunha
    Emmanuelle, Bignon
    Aurelie, Balestra
    Jeremy, Jove
    Pernelle, Noize
    Nicholas, Moore
    Fourrier-Reglat, Annie
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [6] Effectiveness, safety and pattern of bevacizumab (BY) use in 1st-line therapy metastatic colorectal cancer (mCRC) in real-life practice: results of the ETNA cohort study
    Fourrier-Reglat, A.
    Smith, D.
    Ravaud, A.
    Rouyer, M.
    Balestra, A.
    Bernard, M. A.
    Moore, N.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 68 - 68
  • [7] Effectiveness and Safety of Cetuximab as First-line Treatment in the Elderly with Metastatic Colorectal Cancer from the EREBUS Cohort
    Fourrier-Reglat, Annie
    Noize, Pernelle
    Rouyer, Magali
    Smith, Denis
    Francois, Eric
    Monnereau, Alain
    Balestra, Aurelie
    Jove, Jeremy
    Lassalle, Regis
    Moore, Nicholas
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 310 - 310
  • [8] Effectiveness and Safety of Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer According to Frailty in the EREBUS Study
    Gouverneur, Amandine
    Coutureau, Juliette
    Rouyer, Magali
    Smith, Denis
    Francois, Eric
    Monnereau, Alain
    Balestra, Aurelie
    Jove, Jeremy
    Lassalle, Regis
    Moore, Nicholas
    Fourrier-Reglat, Annie
    Noize, Pernelle
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 520 - 521
  • [9] Real-life use of cetuximab as 1st-line treatment of metastatic colorectal cancer in France: evaluation of the conformity with SmPC and guidelines - results of the EREBUS cohort study
    Rouyer, M.
    Fourrier-Reglat, A.
    Mitry, E.
    Francois, E.
    Bignon, E.
    De Sagazan, A. Le Monies
    Jove, J.
    Moore, N.
    Noize, P.
    Smith, D.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 104 - 105
  • [10] Real-life use of cetuximab as 1st-line treatment of metastatic colorectal cancer in France: evaluation of the conformity with SmPC and guidelines - results of the EREBUS cohort study
    Rouyer, M.
    Fourrier-Reglat, A.
    Mitry, E.
    Francois, E.
    Bignon, E.
    de Sagazan, A. L. E. Monies
    Jove, J.
    Moore, N.
    Noize, P.
    Smith, D.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 25 - 25
12345